Industry Relations and Technology Transfer
Who We Are
Vice President, Industry Relations and Clinical Research Support
Ulrich manages operations for the Industry Relations and Technology Transfer, Clinical Research Support and Institutional Review Offices. For more than 12 years, Ulrich has served in leadership roles in business development and technology commercialization at academic and research institutions, including serving as managing director of technology commercialization at the University of Texas M.D. Anderson Cancer Center. He has extensive experience in commercializing university-based technologies, both through licensing transactions as well as through formation of eight start-up companies.
Ulrich earned his doctorate in biochemistry from the Baylor College of Medicine where he completed his post-doctoral fellowship in biochemistry and molecular biology at the University of Texas M.D. Anderson Cancer Center. He also holds a master of science in cell biology from Texas A&M University, and a bachelor of science in microbiology from New Mexico State University.
Kavita V. Shah
Kavita assists in managing the Industry Relations and Technology Transfer Office, protects and commercializes the Center’s intellectual property portfolio and builds large-scale research partnerships between Fred Hutch and industry. Previously, Kavita served as an immunology clinical science manager at Abbott Laboratories where she specialized in marketing, medical information and building research partnerships between Abbott’s Clinical Division and the medical community.
Kavita earned her doctorate in pharmacology and certificate in clinical research training from the University of Washington. She also holds undergraduate degrees in biochemistry and molecular biology and art history from Pennsylvania State University.
Director, Business Development
Richard evaluates startup opportunities, supports startup companies, develops relationships and collaborations with industry, manages and protects intellectual property and out-licenses Fred Hutch technologies. Previously, Richard served as a senior scientist at California Biotechnology, as senior director of pharmacology and strategic alliances at MDS Pharma Services, and as scientific director, marketing and business development at Nastech Pharmaceutical Company.
Richard earned his doctorate in microbiology from the University of Minnesota and completed his postdoctoral training at The Salk Institute in San Diego, Calif. He also holds a bachelor of science in biology from the University of California, Santa Cruz.
Linda performs license administration and management, compliance reporting with federal funding agencies, budget preparation and administration, IRTTO administrative support. Previously, Linda served Fred Hutch as payroll and benefit accounting specialist.
Contracts & Fiscal Manager, Industry Sponsored Agreements
Sonja provides the legal, financial and administrative management of industry sponsored clinical trial agreements as well as overseeing post-award management of industry budgets. Previously, she specialized in negotiating industry-sponsored clinical trial agreements and budgets while working as a sponsored projects officer at Seattle Children’s Research Institute.
Sonja earned her juris doctorate and master of arts from Syracuse University, and her bachelor of arts in political science and Swedish from University of Washington.
Kristi provides administrative support to the Vice President of Industry Relations and Clinical Research Support. She is the initial point of contact for general internal and external IRTTO inquiries and provides office administration and meeting coordination.
Legal Administrative Assistant
Clinton coordinates outgoing material and data transfer agreements, patent annuity and intellectual property management. Before joining the Center, Clinton worked as a docketing manager at the National Institutes of Health Office of Technology Transfer.
Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect
and treat cancer and other life-threatening diseases.